Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

publication venue for

The effect of ketamine on synaptic mistuning induced by impaired glutamate reuptake. 2023
Genomic modules and intramodular network concordance in susceptible and resilient male mice across models of stress.. 47. 2021
White matter in prolonged glucocorticoid response to psychological stress in schizophrenia.. 46. 2021
Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19.. 46. 2021
Late-life depression accentuates cognitive weaknesses in older adults with small vessel disease.. 47. 2021
Accelerated brain aging predicts impulsivity and symptom severity in depression.. 46. 2021
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders.. 46. 2020
Telomere length and human hippocampal neurogenesis.. 45. 2020
Structural brain networks in remitted psychotic depression.. 45. 2020
Contribution of D1R-expressing neurons of the dorsal dentate gyrus and Ca_v1.2 channels in extinction of cocaine conditioned place preference.. 45. 2020
D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction.. 45. 2019
Chronic adolescent exposure to ∆9-tetrahydrocannabinol decreases NMDA current and extrasynaptic plasmalemmal density of NMDA GluN1 subunits in the prelimbic cortex of adult male mice.. 45. 2019
Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels.. 44. 2019
Herbert D. Kleber.. 44. 2019
The polygenic nature of telomere length and the anti-ageing properties of lithium.. 44. 2018
Early life stress leads to sex differences in development of depressive-like outcomes in a mouse model.. 44. 2018
The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway.. 43. 2018
Neural cell adhesion molecule peptide mimetics modulate emotionality: pharmacokinetic and behavioral studies in rats and non-human primates.. 44. 2018
Telomere Length and Bipolar Disorder.. 43. 2018
Narp Mediates Antidepressant-Like Effects of Electroconvulsive Seizures.. 43. 2017
Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator.. 43. 2017
Telomere Length and Bipolar Disorder.. 43. 2017
The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder.. 42. 2017
Cacna1c in the Prefrontal Cortex Regulates Depression-Related Behaviors via REDD1.. 42. 2016
Eberhard H Uhlenhuth.. 41. 2016
Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice.. 41. 2016
Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain.. 41. 2016
Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels.. 41. 2015
Lateral Hypothalamus GABAergic Neurons Modulate Consummatory Behaviors Regardless of the Caloric Content or Biological Relevance of the Consumed Stimuli.. 41. 2015
Alteration of the Centromedial Amygdala Glutamatergic Synapses by the BDNF Val66Met Polymorphism.. 40. 2015
A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.. 40. 2014
Decreased hypothalamic functional connectivity with subgenual cortex in psychotic major depression.. 40. 2014
Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory.. 39. 2014
D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.. 39. 2013
Dopaminergic influences on emotional decision making in euthymic bipolar patients.. 39. 2013
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter.. 38. 2013
Caloric restriction enhances fear extinction learning in mice.. 38. 2013
Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.. 37. 2012
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity.. 37. 2012
Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.. 37. 2012
Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects.. 37. 2011
Genetic association of recovery from eating disorders: the role of GABA receptor SNPs.. 36. 2011
The MATRICS consensus cognitive battery in patients with bipolar I disorder.. 36. 2011
Paradoxical anxiogenic response of juvenile mice to fluoxetine.. 34. 2009
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia.. 34. 2009
Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction.. 34. 2009
TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes.. 34. 2008
Wild-type male offspring of fmr-1+/- mothers exhibit characteristics of the fragile X phenotype.. 33. 2008
Clinical and biological effects of mifepristone treatment for psychotic depression.. 31. 2006
Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.. 31. 2006
Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?. 30. 2005
Association of multiple DRD2 polymorphisms with anorexia nervosa.. 30. 2005
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.. 30. 2005
Effects of serotonin transporter promoter polymorphisms on serotonin function.. 29. 2004
Executive dysfunction, heart disease burden, and remission of geriatric depression.. 29. 2004
Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.. 28. 2003
Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.. 26. 2002
Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.. 26. 2002
Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats.. 25. 2001
Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.. 24. 2001
Glucocorticoid effects on mesotelencephalic dopamine neurotransmission.. 21. 1999
Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage.. 19. 1998
Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle.. 17. 1997
Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls.. 15. 1996
Blunted serotonergic responsivity in depressed inpatients.. 13. 1995
Plasma 10-hydroxynortriptyline and therapeutic response in geriatric depression.. 1. 1988
Correction: The prefrontal cortex, pathological anxiety, and anxiety disorders.. 47. 2022
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?. 40. 2015
Anxiety, the chicken or the egg of addiction: targeting G9a for the treatment of comorbid anxiety and cocaine addiction. 2019
New Insights into the Biology of the BDNF Transcriptional 'Code'. 2016
Can the effects of antidepressants be observed in the first two weeks of treatment? 1997
The prefrontal cortex, pathological anxiety, and anxiety disorders. 2021
Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. 2020
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. 2017
Role of Inflammation in Suicide: From Mechanisms to Treatment. 2016
Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders? 2014
Sensitive periods in affective development: nonlinear maturation of fear learning. 2014
Mechanisms of non-genetic inheritance and psychiatric disorders. 2014
Translational research in late-life mood disorders: implications for future intervention and prevention research. 2007
Report by the ACNP Task Force on response and remission in major depressive disorder. 2006
N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. 1995
On the structural and mechanistic basis of function, classification, and ligand design for 5-HT receptors. 1990

VIVO Weill Cornell Medical College

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)